Chris Stebbings

Chris Stebbings is a seasoned finance professional with extensive experience in capital markets and corporate finance. Currently serving as a Capital Markets Advisor at SkinBioTherapeutics PLC since September 2023, Chris previously held roles at LGB & Co. Limited as both Corporate Relationships Director and Institutional Sales Director from July 2019 to July 2023. Prior positions include Editor at The Twenty Minute VC, Director at RiverRock Strategic Capital Ltd and Parva Capital Ltd, as well as Managing Director at Charles Stanley Securities and Altium Capital. Chris's educational background includes attending Harrow School and Horris Hill in Newbury.